World Asthma Day 2026 collection

The Journal of Allergy and Clinical Immunology: Global

All content of JACI: Global is free to read.

• AIM4 Next Step: Comparing ICS dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation

• Self-directed de-escalation of maintenance inhaler therapy in patients with severe asthma in remission with biologic treatment: An observational study

• Correlates of cockroach nasal challenge responsiveness among sensitized urban children with asthma

• Bronchial thermoplasty for severe asthma: Systematic review and meta-analysis of benefits and harms

• Real-world impact of mepolizumab on pediatric and adolescent patients with severe asthma

The Journal of Allergy and Clinical Immunology: In Practice

• Impact of Dupilumab for Severe Asthma on Fatigue, Quality of Life, Work Productivity, and Activity

• Values and Preferences of Patients and Caregivers Regarding the Management of Moderate-to-Severe Asthma: A Systematic Review and Qualitative Evidence Synthesis

• Adherence to Inhaled Corticosteroids and Clinical Outcomes Following a Year of Tezepelumab Therapy for Severe Asthma

• Impact of Chronic Rhinosinusitis on Long-Term Clinical Outcomes in Adults With Asthma

• Comparative Effectiveness of Tezepelumab and Dupilumab in Asthma: A Multinational Retrospective Cohort Study

Read the full Asthma Collection from JACI: In Practice here

The Journal of Allergy and Clinical Immunology

• The rhinovirus puzzle: Linking virus and host factors to childhood asthma

• From genotype to phenotype in early childhood asthma

• AZD8630/AMG 104, an inhaled Anti-TSLP antibody fragment, for moderate-to-severe asthma: a phase 1 randomized controlled trial

• High airway thymic stromal lymphopoietin in asthma is associated with type 2 inflammation, mucus plugging, and airway remodeling

• First-in-human study for londamocitinib (AZD4604), an inhaled selective JAK1 inhibitor

Read the full Asthma Collection from JACI here